文献速递冠心病

高出血风险患者行经皮冠状动脉介入治疗的长期结局:韩国全国注册研究

Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
PubMed 文献 · Eur Heart J · 2024-01-01

基于韩国全国医保数据库2009–2018年325 417例行PCI的稳定心绞痛或急性冠脉综合征患者,按ARC-HBR标准分为高出血风险组(66 426例,20.4%)与非高出血风险组,比较长期出血与缺血事件风险。高出血风险组大出血(23.9% vs 8.9%)和缺血事件(33.8% vs 14.4%)均显著更高,全因死亡风险也更高。

要点

  • 高出血风险患者PCI后长期大出血和缺血事件风险均显著高于非高出血风险患者。
  • 高出血风险与全因死亡风险升高相关(HR 3.73,95%CI 3.66–3.79)。
  • PCI后第一年内,单一主要标准者年均大出血率为5.5%,单一次要标准者为2.9%。

核心结论

  • 行PCI的高出血风险患者长期出血、缺血事件及死亡风险均显著高于非高出血风险患者。

研究设计与样本

  • 韩国全国队列研究,基于韩国健康保险审查评价院数据库,纳入2009–2018年诊断为稳定心绞痛或急性冠脉综合征并接受PCI的患者。
  • 共纳入325 417例患者,按ARC-HBR标准分为高出血风险组(66 426例,20.4%)和非高出血风险组。
  • 共同主要结局为大出血事件和缺血事件(心源性死亡、心肌梗死和缺血性卒中的复合终点)。

主要发现

  • 高出血风险组大出血事件发生率为23.9%,非高出血风险组为8.9%(P < .001)。
  • 高出血风险组缺血事件发生率为33.8%,非高出血风险组为14.4%(P < .001)。
  • 高出血风险与大出血事件相关(HR 3.12,95%CI 3.04–3.21,P < .001)。
  • 高出血风险与缺血事件相关(HR 2.50,95%CI 2.45–2.56,P < .001)。
  • 高出血风险与全因死亡风险升高相关(HR 3.73,95%CI 3.66–3.79,P < .001)。

关键数值与推荐

  • 高出血风险定义采用学术研究联合会(ARC)HBR标准。
  • PCI后第一年内,符合单一主要标准者大出血年均发生率为5.5%,符合单一 minor 标准者为2.9%。

临床怎么用

  • 对行PCI的患者应依据ARC-HBR标准评估高出血风险,识别出血与缺血双重高风险人群。
  • 高出血风险患者PCI后需长期关注出血和缺血事件,并警惕死亡风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI) are at increased risk of not only bleeding, but also ischaemic events. This study aimed to determine the long-term relative risk of ischaemic and bleeding events in HBR patients. METHODS: This study was a nationwide cohort study, based on the Korean National Health Insurance Review and Assessment Service database. Patients diagnosed with stable angina or acute coronary syndrome and those who underwent PCI in Korea between 2009 and 2018 were included in the analysis. According to the Academic Research Consortium HBR criteria, the total population was divided into HBR and non-HBR groups. The co-primary outcomes were major bleeding events and ischaemic (composite of cardiac death, myocardial infarction, and ischaemic stroke) events. RESULTS: Among a total of 325 417 patients who underwent PCI, 66 426 patients (20.4%) had HBR. During the follow-up period, HBR patients had a higher risk for major bleeding events (23.9% vs. 8.9%, P < .001) and ischaemic events (33.8% vs. 14.4%, P < .001). However, the impact of HBR was significant for major bleeding events [hazard ratio (HR) 3.12, 95% confidence interval (CI) 3.04-3.21, P < .001] and for ischaemic events (HR 2.50, 95% CI 2.45-2.56, P < .001). The HBR group was also associated with a greater risk of all-cause mortality (HR 3.73, 95% CI 3.66-3.79, P < .001). The average annual rate of major bleeding events within the first year after PCI was 5.5% for a single major criterion, and 2.9% for a single minor criterion. CONCLUSIONS: Among patients undergoing PCI, those with HBR were at increased long-term risk for both bleeding and ischaemic events, with a greater risk of mortality compared to non-HBR patients.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Kang, Yun, Park, et al. Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry. Eur Heart J. 2024. PMID: 39042715. doi:10.1093/eurheartj/ehae462

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。